Dow Up0.41% Nasdaq Up1.23%

Merck & Co. Inc. (MRK)

-NYQ

48.74 Oct 1, 4:00PM EDT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2012Dec 31, 2011Dec 31, 2010
Net Income 6,168,000   6,272,000   861,000  
Operating Activities, Cash Flows Provided By or Used In
Depreciation6,978,000  7,427,000  7,381,000  
Adjustments To Net Income881,000  (670,000)1,529,000  
Changes In Accounts Receivables349,000  (1,168,000)(1,089,000)
Changes In Liabilities(2,800,000)1,342,000  189,000  
Changes In Inventories(482,000)(678,000)1,990,000  
Changes In Other Operating Activities(1,203,000)(262,000)(160,000)
Total Cash Flow From Operating Activities 10,022,000   12,383,000   10,822,000  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(1,954,000)(1,723,000)(1,678,000)
Investments(5,058,000)(1,001,000)(2,636,000)
Other Cash flows from Investing Activities207,000  (166,000)817,000  
Total Cash Flows From Investing Activities (6,805,000) (2,890,000) (3,497,000)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid(5,236,000)(4,811,000)(4,853,000)
Sale Purchase of Stock(1,281,000)(1,600,000)(1,230,000)
Net Borrowings3,164,000  (471,000)748,000  
Other Cash Flows from Financing Activities86,000  (22,000)(106,000)
Total Cash Flows From Financing Activities (3,267,000) (6,904,000) (5,441,000)
Effect Of Exchange Rate Changes(30,000)42,000  (295,000)
Change In Cash and Cash Equivalents (80,000) 2,631,000   1,589,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.